In vitro placental model optimization for nanoparticle transport studies.
about
Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentGestational nanomaterial exposures: microvascular implications during pregnancy, fetal development and adulthoodCuprous oxide nanoparticles selectively induce apoptosis of tumor cellsTransfer of Silver Nanoparticles through the Placenta and Breast Milk during in vivo Experiments on RatsDemonstration of the clathrin- and caveolin-mediated endocytosis at the maternal-fetal barrier in mouse placenta after intravenous administration of gold nanoparticles.A comparative study of five physiological key parameters between four different human trophoblast-derived cell lines.Oxcarbazepine-loaded polymeric nanoparticles: development and permeability studies across in vitro models of the blood-brain barrier and human placental trophoblast.Progress and future of in vitro models to study translocation of nanoparticles.Kinetics of silica nanoparticles in the human placenta.Transport of digoxin-loaded polymeric nanoparticles across BeWo cells, an in vitro model of human placental trophoblast.Preparation, characterization, and transport of dexamethasone-loaded polymeric nanoparticles across a human placental in vitro model.Magnetic Nanoparticles Interact and Pass an In Vitro Co-Culture Blood-Placenta Barrier Model.Dendritic polyglycerol nanoparticles show charge dependent bio-distribution in early human placental explants and reduce hCG secretion.An advanced human in vitro co-culture model for translocation studies across the placental barrier.Engineered nanomaterial applications in perinatal therapeutics.HPLC Method Development for Quantification of Doxorubicin in Cell Culture and Placental Perfusion Media.
P2860
Q26766128-9CBC0977-EE81-4A02-9507-4CCD10AD6C13Q28383364-0E928F8B-66D4-45D9-B2FA-94C33E68991DQ28385293-6E408C37-538A-4464-A469-38B11F34D5B2Q28392147-2FCA7CFB-6C4E-444B-98FE-B0D4EDE191B3Q33579532-45C2DB81-2D74-49A4-A33E-88A53BA7A8FEQ33918875-7F7C5FD4-1AEC-45C6-96BF-2C828E3ACBB2Q35185771-6A57A99B-17B7-4646-BF6B-A68AAC23DA6AQ36001471-3F20BDB4-5AF9-46B9-9DDB-EBC5E746FD6FQ36263478-BDE66382-704C-4E27-93EF-D92E6C3C1DFBQ37158671-EAF8B9B6-49E6-463E-880A-302C10DB9FBCQ37238557-58F6544A-5100-4E05-AD40-9FAC44076F34Q50002357-F2567D65-7FE5-4D3B-A490-5790E207232FQ50046151-BA024D7D-2154-48EC-967E-719B97ED3BA4Q52620795-C6C8B347-8BCD-4991-9F55-BC0CAD99A6D9Q55058004-1184FE26-0935-4018-A9E7-A0993ECCC44FQ55497152-C483B028-6288-42B4-913D-5B3DDBCC96F2
P2860
In vitro placental model optimization for nanoparticle transport studies.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
In vitro placental model optimization for nanoparticle transport studies.
@ast
In vitro placental model optimization for nanoparticle transport studies.
@en
type
label
In vitro placental model optimization for nanoparticle transport studies.
@ast
In vitro placental model optimization for nanoparticle transport studies.
@en
prefLabel
In vitro placental model optimization for nanoparticle transport studies.
@ast
In vitro placental model optimization for nanoparticle transport studies.
@en
P2093
P2860
P50
P356
P1476
In vitro placental model optimization for nanoparticle transport studies.
@en
P2093
Erik Rytting
Giulio Pojana
Laura Cartwright
Marie Sønnegaard Poulsen
P2860
P304
P356
10.2147/IJN.S26601
P407
P577
2012-01-31T00:00:00Z